Clinical trial
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)
NCT00095069 · H. Lundbeck A/S, Industry · Completed
Key facts
| NCT number | NCT00095069 |
|---|---|
| Title | Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) |
| Official title | A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Groups Efficacy and Safety Extension Study of MK0928 in the Treatment of Adult Outpatients With Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | MK0928, gaboxadol / Duration of Treatment - 1 year, Comparator: placebo / Duration of Treatment -1 year |
| Enrollment | 600 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Nov 1, 2004 |
| Last update posted | Jan 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: